Sweet sensors lecture 8 resources


Published on

Published in: Education, Business
1 Like
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • Team introduction, glucose meter for detection of targets other than glucose; a device/strip to use with a glucometer for detection of non-glucose targets.
  • the old days of one wonder drug to cure all patients is gone and most pharmaceutical company is facing drugs are safe and effective to only certain populations. Therefore close and daily monitoring of therapeutic drugs is required.
  • Sweet sensors lecture 8 resources

    1. Sweet SensorsSmall form factor Types of targetsdiagnostic devices thatcan detect a variety of • Recreational drugsbiological markers. • Heavy metals • Toxins• Inexpensive • Bacteria• Quantitative • Viruses• Adaptable to many • Pharmaceuticals kinds of tests (targets) • Environmental hazards • Food safety targets Yu Xiang and Yi Lu, Nature Chem. 3, 697-703 (2011).
    2. Meetings/Conversations From the Past Week• Tecan group – Global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics.• Teleconference with Director of Strategic Alliances and three of her associates in a major pharmaceutical company• Abbott• Director of Economic & Technical Development Zone, Shanghai China• Food Safety and Quality Conference• Dr. Bill Olson, Market Medical Director - Pacific Region United Healthcare
    3. Upcoming Conversations• Sword Diagnostics• Abbott Labs• Blue Cross Blue Shield innovation team• Retired Hospital executive• Biotech entrepreneur• Michael Rosen, life sciences entrepreneur and executive• Other VCs
    4. Key findings:• Big pharma company is interested in low cost drug monitoring during clinical trials and after the drugs are approved to ensure safety and effectiveness of the drug to individual patients – Site visit in December• Work with glucose meter manufacturers – Our technology makes a particular glucose meter more competitive on the market• Look for biomarkers for diseases that associated with diabetes• Invitation to give a presentation @Abbott in December• Emergency room, rapid toxicology screen
    5. Business Model Canvas # 8 Yi Lu, Tian Lan, Brian Wong Sweet Sensors Neil Kane 11-15-2011 Chris Sorensen Conferences R&DPharmaceutical Immediate results Pharmaceuticalcompanies Publicity companies Direct Convenient monitoringDiagnostics Insurance Reimbursement and safer dosage Long termcompanies Diagnostic Robust/extensible companiesContract researchorganizations Inexpensive Contract research organizations Simple Pharmaceutical Cos IP InvestorsGlucometer mfr Personnel Pharmaceutical CosStrip mfr Licensing Licensing? R&D Product Sales
    6. Partners • As noted on the Business Model Canvas, key partners are pharmaceutical companies and glucose meter manufacturers. Sweet SensorsGlucose meter Pharmaceutical /manufacturer • Added value for meter diagnostic companies• Meter engineering manufacturers • Provide the target of• Strip design • Low cost, fast interest• FDA approval monitoring improves • Key customers clinical trials • Key market knowledge
    7. Action plan• Put together a compelling presentation and go pitch pharmaceutical companies and diagnostic companies. We’re getting inconclusive results talking to KOLs and consultants.• We are on second revision of a pitch to use.
    8. Sweet Sensor Revenue Model Factors COPD MARKET All Segments Market Size 16,000,000 Revenue Model Market Share Target 10% Channel Capacity 100% Customer Activations 1,600,000 Attrition 10% Net Customers 1,440,000 Missing: Revenue Model Usage per Year 52Lifetime value of customer Number of Uses per Year Revenue per Use $4 74,880,000 $4and amortization of Total revenue $299,520,000acquisition costs over EXPENSES Cost Per Customer Acquisition $25 $25lifetime Cust. Acquisiiton Expense $40,000,000 Channel Split 30% 30% Cost of Channel Sales $89,856,000 COGS $0.25 $18,720,000 Net Operating Income $150,944,000 Operating Margin 50% Operating Expenses GSA $5,000,000 EBIDTA $145,944,000 Net Margin 49%
    9. Service Channel Distribution Model Payment Insurance Doctor Company Medical Payment Services Data Service Service Provider Patient “Healthways” In House Care Services Payment Sweet Sensors